Biofrontera received patent approval for the revised formulation of Ameluz ® in April 2025, extending patent protection through to December 2043. The Orange Book is published by the U.S. Food and Drug ...
When Jürgen Hambrecht of BASF and Andrew N. Liveris of Dow Chemical, the heads of the world's two largest chemical companies, meet to break ground for a new chemical plant, it can be read as a strong ...
Propylene oxide (PO), formally 2-methyloxirane, is low-boiling liquid that is useful for making many commercial materials. It was known as long ago as 1866, when Eduard Linnemann at the University of ...
WOBURN, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company focused on the development and commercialization of photodynamic therapy (PDT), today ...